Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial (STABILITY)

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: November 26, 2008
Last updated: July 9, 2015
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2013
  Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 27, 2014